CORE ADANIPORTS+0.24% BIRET-0.24% BRIGADE-0.85% DLF-1.17% EMBASSY+1.10% GMRAIRPORT+0.00% GODREJPROP+0.19% IRB+3.46% LODHA-0.98% LT-1.76% MAHLIFE-1.64% MINDSPACE-1.39% NCC-0.64% OBEROIRLTY-0.14% PHOENIXLTD+0.11% PRESTIGE-0.22% SOBHA+0.95% as of 2026-08-26 16:27 UTC

The Annexure

Desk Healthcare Decipher Labs Ltd

Decipher Labs Ltd

BSE 524752 DECIPHER INE643N01012
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Filing rhythm · 60 trading days

8 filings · 4 material · busiest 2026-08-13

What it files

Filings

8 in the window

  1. 14 August 2026

    General

    Announcements Under Regulation 30 Of SEBI (LODR), Regulations, 2015.

    Announcement under Regulation 30 of SEBI (Listng Obligations and Disclosure Requirement), Regulations, 2015.

    Company Update / General View filing →

  2. 13 August 2026

    Board Outcome

    Board Meeting Outcome for Outcome Of Board Meeting

    Outcome of Board Meeting held on 13th August, 2026.

    Board Meeting / Outcome of Board Meeting View filing →

  3. 13 August 2026

    Results

    Financial Results For The Quarter Ended 30.06.2026.

    Unaudited Financial Results (Standalone and Consolidated) for the quarter ended 30.06.2026.

    Result / Financial Results View filing →

  4. 13 August 2026

    Change in Directorate

    Change in Directorate

    Appointment of Mr. Bhupendralal Waghray as an Additional Director (Independent Category) of the company for a period of Five (5) years w.e.f. 13.08.2026 subject to approval of shareholders.

    Company Update / Change in Directorate View filing →

  5. 13 August 2026

    Results

    Revised Un-Audited Financial Results For The Quarter Ended 30.06.2026.

    Revised Un-audited Financial Results for the quarter ended 30.06.2026.

    Result / Financial Results View filing →

  6. 6 August 2026

    Board Meeting

    Board Meeting Intimation for Meeting Scheduled To Be Held On 13Th August, 2026.

    Decipher Labs Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve 1. Un-audited financial results ....

    Board Meeting / Board Meeting View filing →

  7. 16 July 2026

    Compliance Certificate

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Compliance as per Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30.06.2026

    Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

  8. 24 June 2026

    Trading Window

    Closure of Trading Window

    Closure of trading window for the period ending 30th June, 2026

    Insider Trading / SAST / Closure of Trading Window View filing →